Clinical characteristics and outcome of childhood de novo acute myeloid leukemia in Saudi Arabia: A multicenter SAPHOS leukemia group study

被引:14
|
作者
Jastaniah, Wasil [1 ,2 ]
Al Ghemlas, Ibrahim [3 ,4 ]
Al Daama, Saad [5 ]
Ballourah, Walid [6 ]
Bayoumy, Mohammad [7 ]
Al-Anzi, Faisal [8 ]
Al Shareef, Omar [9 ]
Alsultan, Abdulrahman [10 ]
Abrar, Mohammed Burhan [2 ]
Al Sudairy, Reem [11 ]
机构
[1] Umm AlQura Univ, Fac Med, Dept Pediat, Mecca, Saudi Arabia
[2] King Abdul Aziz Med City, Princess Noorah Oncol Ctr, Jeddah, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia
[4] Alfaisal Univ, Fac Med, Riyadh, Saudi Arabia
[5] King Fahad Specialist Hosp, Dammam, Saudi Arabia
[6] King Fahad Med City, Riyadh, Saudi Arabia
[7] King Faisal Specialist Hosp & Res Ctr, Jeddah, Saudi Arabia
[8] Prince Faisal Bin Bandar Canc Ctr, Qaseem, Saudi Arabia
[9] Prince Sultan Mil Med City, Riyadh, Saudi Arabia
[10] King Saud Univ, Coll Med, Dept Pediat, Riyadh, Saudi Arabia
[11] King Abdul Aziz Med City, King Abdullah Specialized Childrens Hosp, Dept Pediat Hematol Oncol, Riyadh, Saudi Arabia
关键词
AML; Acute leukemia; Ethnic; Response; Risk; Developing; CHILDRENS-ONCOLOGY-GROUP; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; PEDIATRIC AML; CURRENT CONTROVERSIES; SUPPORTIVE CARE; CANCER-GROUP; TRIAL; RISK; ADOLESCENTS;
D O I
10.1016/j.leukres.2016.08.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Geographic variation and ethnicity have been implicated to influence the outcome of pediatric acute myeloid leukemia (AML). Furthermore, survival outcomes from developing countries are reported to be inferior to developed nations. We hypothesized that risk-and response-based outcome in high-income resource-rich developing countries would be comparable to developed nations as access to care and supportive measures would be similar. A total of 193 children diagnosed with de novo AML between January 2005 and December 2012 were identified, of those 175 were evaluable for outcome. Patients were stratified into low-risk (LR), intermediate-risk (IR), or high-risk (HR) groups. The complete remission (CR), early death, and induction failure rates were: 85.7%, 2.3%, and 12%; respectively. The 5-year cumulative incidences of relapse (CIR) and non-relapse mortality (NRM) were 43.1% and 9.8% respectively; overall survival (OS) was 58.8 +/- 4% and event-free survival (EFS) 40.9 +/- 4.1%. The 5-year OS for LR, IR, and HR groups were 72.0 +/- 6.9%, 59.8 +/- 6.2%, and 45.1 +/- 7.4%; respectively (p = 0.003); and EFS 50.5 +/- 8.0%, 46.3 +/- 6.4%, and 23.3 +/- 6.4%; respectively (p = 0.001). This study demonstrated comparable outcomes to those reported from developed countries. This suggests that utilization of risk-and response based protocols in developing countries can overcome ethnic and geographic variation, if access to care and supportive measures were similar. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 50 条
  • [31] Clinical studies of acute myeloid leukemia in the Japan Adult Leukemia Study Group
    Shuichi Miyawaki
    International Journal of Hematology, 2012, 96 : 171 - 177
  • [32] Overexpression of BAALC: clinical significance in Chinese de novo acute myeloid leukemia
    Jing-dong Zhou
    Lei Yang
    Ying-ying Zhang
    Jing Yang
    Xiang-mei Wen
    Hong Guo
    Dong-ming Yao
    Ji-chun Ma
    Qin Chen
    Jiang Lin
    Jun Qian
    Medical Oncology, 2015, 32
  • [33] Overexpression of BAALC: clinical significance in Chinese de novo acute myeloid leukemia
    Zhou, Jing-dong
    Yang, Lei
    Zhang, Ying-ying
    Yang, Jing
    Wen, Xiang-mei
    Guo, Hong
    Yao, Dong-ming
    Ma, Ji-chun
    Chen, Qin
    Lin, Jiang
    Qian, Jun
    MEDICAL ONCOLOGY, 2015, 32 (01)
  • [34] Ploidy and clinical characteristics of childhood acute myeloid leukemia: A NOPHO-AML study
    Sandahl, Julie Damgaard
    Kjeldsen, Eigil
    Abrahamsson, Jonas
    Ha, Shau-Yin
    Heldrup, Jesper
    Jahnukainen, Kirsi
    Jonsson, Olafur G.
    Lausen, Birgitte
    Palle, Josefine
    Zeller, Bernward
    Forestier, Erik
    Hasle, Henrik
    GENES CHROMOSOMES & CANCER, 2014, 53 (08): : 667 - 675
  • [35] Correlation of clinical outcome and prognostic factors in a group of acute de novo myeloblastic leukemia patients.
    Arana, R
    Montiel, CL
    Sanchez, E
    Ignacio, G
    Delgado, LJ
    Baltasar, S
    Vega, P
    Castro, MA
    Duque, J
    Jiménez, R
    Lobato, R
    Martinez, MA
    Rubio-Borja, ME
    BLOOD, 2001, 98 (11) : 208B - 208B
  • [36] CYTOGENETIC PROFILE AND FLT3 MUTATION OF 100 ADULT DE NOVO ACUTE MYELOID LEUKEMIA PATIENTS FROM SAUDI ARABIA: CORRELATION TO BIOLOGIC FACTORS AND OUTCOME
    Elyamany, G.
    Elghezal, H.
    Alsuhaibani, O.
    Fadalla, K.
    Awad, M.
    Bouhajar, I. Ben-Abdallah
    Osman, H.
    Elborai, Y.
    Elarja, A.
    AL-Fayez, K.
    Al-Abulaaly, A.
    HAEMATOLOGICA, 2014, 99 : 577 - 578
  • [37] Clinicopathologic characteristics of de novo NF1-mutated acute myeloid leukemia
    Zhang, Bo
    Mahsoub, Sameh
    Weinberg, Olga
    Germans, Sharon Koorse
    LEUKEMIA & LYMPHOMA, 2024, 65 (12) : 1917 - 1920
  • [38] A cytogenetic study of 553 de novo acute myeloid leukemia patients in Greece
    Daraki, Aggeliki
    Roumelioti, Marten
    Diamantopoulou, Paraskevi
    Karakosta, Maria
    Pantelias, Gabriel
    Sambani, Constantino
    Manola, Kalliopi
    CHROMOSOME RESEARCH, 2011, 19 : S134 - S135
  • [39] Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia
    Schmaelter, Ann-Kristin
    Labopin, Myriam
    Socie, Gerard
    Itala-Remes, Maija
    Blaise, Didier
    Yakoub-Agha, Ibrahim
    Forcade, Edouard
    Cornelissen, Jan
    Ganser, Arnold
    Beelen, Dietrich
    Labussiere-Wallet, Helene
    Passweg, Jakob
    Savani, Bipin N.
    Schmid, Christoph
    Nagler, Arnon
    Mohty, Mohamad
    BLOOD CANCER JOURNAL, 2020, 10 (03)
  • [40] Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia
    Ann-Kristin Schmaelter
    Myriam Labopin
    Gerard Socié
    Maija Itälä-Remes
    Didier Blaise
    Ibrahim Yakoub-Agha
    Edouard Forcade
    Jan Cornelissen
    Arnold Ganser
    Dietrich Beelen
    Hélène Labussière-Wallet
    Jakob Passweg
    Bipin N. Savani
    Christoph Schmid
    Arnon Nagler
    Mohamad Mohty
    Blood Cancer Journal, 10